Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03225859 · ClinicalTrials.gov registry record · NA

A Self-Management Program for Completers of Trauma-Focused Therapy for PTSD

A NA study of Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT03225859: Completed NA study of Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.

NCT03225859 is a NA study of Post Traumatic Stress Disorder that has completed, run by VA Office of Research and Development. The registered enrollment target is 12 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03225859, a NA study of Post Traumatic Stress Disorder, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Veterans who complete trauma-focused therapies (TFTs) report improvements in posttraumatic stress disorder symptoms, quality of life, and social and role functioning. However, many also report uncertainty regarding their ability to maintain and build upon progress made during TFTs following the end of treatment. Veterans who recently completed a course of TFT believe the likelihood of their ongoing success would be bolstered by mental health services that support additional practice and reinforcement of skills learned in TFT. Currently no evidence-based approach for post-TFT care exists; however, Veterans' reported treatment needs are well-suited to a therapist-assisted self-management approach. The objective of this project is to complete Stage 1 (intervention refinement and piloting) of the Stage Model of Treatment Development for a post-TFT therapist-assisted self-management program designed to help Veterans maintain or build upon gains made in TFT, increase self-efficacy for managing their PTSD symptoms, and enhance community engagement. The aims of the project are to: 1) Refine a self-management treatment protocol through eliciting feedback from experienced TFT providers on a draft of the self-management program, 2) Conduct a pilot open trial to assess the acceptability and feasibility of the self-management program, and 3) Explore the effects of the program on Veterans' confidence in managing their PTSD and Veterans' functioning, quality of life, community engagement, and mental health symptoms.

Primary Outcome

Measures treatment rationale credibility in clinical outcome studies (range 1-9; higher scores = higher credibility).

Interventions

  • BEHAVIORAL Self-Management Program

Study Locations (1)

Minnesota

  • Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2018-11-05
Est. Completion 2020-02-28
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT03225859 record still lists

NCT03225859 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Self-Management Program is the first listed.

NCT03225859 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT03225859 about?

NCT03225859 is a clinical study titled "A Self-Management Program for Completers of Trauma-Focused Therapy for PTSD". Veterans who complete trauma-focused therapies (TFTs) report improvements in posttraumatic stress disorder symptoms, quality of life, and social and role functioning. However, many also report uncertainty regarding their ability to maintain and build upon progress made during TFTs following the end ...

What is the current status of trial NCT03225859?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-11-05. Estimated completion is 2020-02-28.

What conditions does trial NCT03225859 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder.

What interventions are being tested in trial NCT03225859?

The interventions under investigation include: Self-Management Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03225859?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03225859 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03225859's enrollment target sits among peer trials

12 248th of 262 higher than 14 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03225859, the US trial registry maintained by the National Library of Medicine. NCT03225859 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.